Status: current, Defined. Date: 30-Sep 2019. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4191251000168111 | Adrenalift (Astragalus membranaceus extract 32.5 mg + Cordyceps sinensis extract 100 mg + Eleutherococcus senticosus extract 26.67 mg + Ganoderma lucidum extract 35 mg + Panax ginseng extract 32.5 mg + Panax quinquefolius extract 30 mg + Withania somnifera extract 40 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4191261000168113 | Adrenalift tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Adrenalift tablet, 60, bottle | has TPUU | True | Adrenalift tablet | Inferred relationship | Some | 1 |
Adrenalift tablet, 30 | has TPUU | True | Adrenalift tablet | Inferred relationship | Some | 1 |
Adrenalift tablet, 60 | has TPUU | True | Adrenalift tablet | Inferred relationship | Some | 1 |
Adrenalift tablet, 30, bottle | has TPUU | True | Adrenalift tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set